Cargando…
Gadofullerene nanoparticles for robust treatment of aplastic anemia induced by chemotherapy drugs
Aplastic anemia (AA) is characterized as hypoplasia of bone marrow hematopoietic cells and hematopenia of peripheral blood cells. Though the supplement of exogenous erythropoietin (EPO) has been clinically approved for AA treatment, the side-effects hinder its further application. Here a robust trea...
Autores principales: | Jia, Wang, Zhen, Mingming, Li, Lei, Zhou, Chen, Sun, Zihao, Liu, Shuai, Zhao, Zhongpu, Li, Jie, Wang, Chunru, Bai, Chunli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295067/ https://www.ncbi.nlm.nih.gov/pubmed/32550910 http://dx.doi.org/10.7150/thno.46794 |
Ejemplares similares
-
Gadofullerene inhibits the degradation of apolipoprotein B100 and boosts triglyceride transport for reversing hepatic steatosis
por: Zhou, Chen, et al.
Publicado: (2020) -
Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer
por: Han, Zheng, et al.
Publicado: (2017) -
APC/C is essential for hematopoiesis and impaired in aplastic anemia
por: Wang, Jia, et al.
Publicado: (2017) -
Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018) -
Author Correction: Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer
por: Han, Zheng, et al.
Publicado: (2018)